Financials
Income statement
Fiscal date | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
---|---|---|---|---|
Total reported revenue | 23.9T | 23.8T | 26.3T | 37.2T |
Cost of revenue | 21.6T | 21.5T | 23.5T | 34.0T |
Gross profit | 2.3T | 2.3T | 2.8T | 3.2T |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.0T | 850.7B | 804.6B | 545.0B |
Other operating expenses | 240.4B | 120.5B | 231.3B | 335.9B |
Operating income | 260.3B | 611.1B | 963.2B | 1.3T |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 78.6B | 172.1B | 190.7B | 133.2B |
Other income expense | — | — | — | — |
Pretax income | 126.5B | 459.7B | 791.2B | 1.1T |
Tax provision | 59.8B | 129.7B | 195.7B | 241.7B |
Net income | 66.7B | 329.9B | 595.6B | 867.3B |
Basic EPS | — | — | 310 | — |
Diluted EPS | — | — | 310 | — |
Basic average shares | — | — | 1.9B | — |
Diluted average shares | — | — | 1.9B | — |
EBITDA | 423.4B | 848.8B | 1.2T | 1.5T |
Net income from continuing op. | — | — | — | — |
Minority interests | 2M | 0 | -1M | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |